AnaptysBio Inc (ANAB)
25.72
+0.10
(+0.39%)
USD |
NASDAQ |
May 08, 16:00
25.72
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Cash from Investing (TTM): 144.75M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 144.75M |
| September 30, 2023 | 117.07M |
| June 30, 2023 | 54.00M |
| March 31, 2023 | 3.463M |
| December 31, 2022 | -394.84M |
| September 30, 2022 | -483.04M |
| June 30, 2022 | -439.76M |
| March 31, 2022 | -330.81M |
| December 31, 2021 | 38.84M |
| September 30, 2021 | 109.13M |
| June 30, 2021 | 103.02M |
| March 31, 2021 | 140.45M |
| December 31, 2020 | 94.48M |
| September 30, 2020 | 94.91M |
| June 30, 2020 | 150.04M |
| March 31, 2020 | 132.52M |
| December 31, 2019 | 131.43M |
| Date | Value |
|---|---|
| September 30, 2019 | -38.75M |
| June 30, 2019 | -74.00M |
| March 31, 2019 | -134.94M |
| December 31, 2018 | -142.45M |
| September 30, 2018 | -129.36M |
| June 30, 2018 | -154.47M |
| March 31, 2018 | -213.83M |
| December 31, 2017 | -243.06M |
| September 30, 2017 | -90.00M |
| June 30, 2017 | -89.51M |
| March 31, 2017 | -27.10M |
| December 31, 2016 | -0.05M |
| September 30, 2016 | -0.091M |
| June 30, 2016 | -0.175M |
| March 31, 2016 | -0.193M |
| December 31, 2015 | -0.238M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-483.04M
Minimum
Sep 2022
150.04M
Maximum
Jun 2020
-23.53M
Average
94.48M
Median
Dec 2020
Cash from Investing (TTM) Benchmarks
| XOMA Corp | -0.711M |
| Fate Therapeutics Inc | 112.66M |
| Ocular Therapeutix Inc | -6.087M |
| Apellis Pharmaceuticals Inc | -0.674M |
| Sutro Biopharma Inc | -3.924M |